IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells

BACKGROUND: In a recent phase II clinical trial for HNSCC patients, IRX-2, a cell-derived biologic, promoted T-cell infiltration into the tumor and prolonged overall survival. Mechanisms responsible for these IRX-2-mediated effects are unknown. We hypothesized that IRX-2 enhanced tumor antigen-(TA)-...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Schilling, Bastian, Harasymczuk, Malgorzata, Schuler, Patrick, Egan, James, Ferrone, Soldano, Whiteside, Theresa L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3567103/
https://ncbi.nlm.nih.gov/pubmed/23408925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0047234
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller